TRIB1 rs780632: Circulating Lipids and Genetic Markers
The variant rs780632 is an intronic single nucleotide polymorphism located in genomic proximity to TRIB1 (tribbles pseudokinase 1). In large-scale genome-wide association studies, common variation across the TRIB1 locus has been robustly associated with differences in circulating blood lipid concentrations, particularly low-density lipoprotein cholesterol (LDL-C) and serum triglycerides. Carried widely throughout human populations, rs780632 serves as an informative genetic marker that reflects baseline statistical variation in lipid biology rather than a direct clinical diagnosis.
What each genotype means
Baseline lipid profile
This genotype represents the common baseline state for this genetic location. Research indicates that individuals with this genotype do not carry the specific variant associated with altered TRIB1 expression levels linked to lipid metabolism. This is considered the reference state in most population studies regarding this specific marker.
Carried by approximately 25-35% of individuals of European ancestry, though frequencies vary significantly across global populations.
Intermediate lipid association
Carrying one copy of this variant is associated with modest differences in circulating triglyceride and LDL cholesterol levels in large-scale population studies. The TRIB1 gene plays a role in lipid metabolism, and this variant is thought to influence its expression, though the exact biological mechanism remains a subject of ongoing research. This association is statistical in nature and does not predict individual health outcomes.
Carried by roughly 40-50% of people of European ancestry, making it a very common genetic profile.
Elevated lipid association
Individuals with two copies of this variant have been shown in genome-wide association studies to have a higher statistical likelihood of altered triglyceride and LDL cholesterol levels compared to those without the variant. Because this is a complex trait influenced by many genes and lifestyle factors, this genotype is only one small piece of your overall metabolic profile. Please discuss your lipid levels and any concerns about cardiovascular health with your clinician.
Carried by approximately 20-30% of individuals of European ancestry, with varying prevalence in other global populations.
Genomic Location and Physical Context
Single nucleotide polymorphisms (SNPs) like rs780632 represent single-letter DNA variations that occur across the human genome. The rs780632 variant resides within an intronic (non-protein-coding) genomic sequence. Non-coding intronic variants do not directly alter the amino acid sequence of any protein. Instead, they frequently act as regulatory markers or expression quantitative trait loci (eQTLs). In high-throughput genomic mapping, rs780632 is positioned within a broader regulatory neighborhood that has been mapped near TRIB1 and flanking genes such as RSU1 and CUBN. Because many variants within a genetic region are inherited together in blocks of linkage disequilibrium, a non-coding SNP often tags surrounding functional regulatory elements that control how and when nearby transcripts are expressed in metabolic tissues like the liver.
Biological Role of the TRIB1 Locus
The TRIB1 gene encodes tribbles pseudokinase 1, an intracellular scaffolding protein that plays a critical role in modulating fundamental cellular signaling cascades, including the mitogen-activated protein kinase (MAPK) and JNK pathways. Unlike conventional protein kinases, pseudokinases lack catalytic kinase activity; they function primarily as molecular adaptors that bind other proteins to regulate their stability, post-translational modification, and proteasomal degradation. In mammalian physiology, TRIB1 is highly expressed in hepatocytes, where it acts as a pivotal regulator of hepatic lipogenesis and lipid clearance. Experimental studies in model organisms have shown that hepatic overexpression of TRIB1 significantly reduces plasma triglycerides and cholesterol levels, whereas knockout or depletion of TRIB1 leads to increased hepatic VLDL production, elevated circulating triglycerides, and altered LDL clearance. Consequently, inherited variations that fine-tune hepatic TRIB1 transcription directly influence systemic lipoprotein homeostasis.
GWAS Findings and Evidence Strength
Genome-wide association studies conducted by global consortia—including the Global Lipids Genetics Consortium (GLGC)—have repeatedly linked common variation across the TRIB1 region to blood lipid profiles. In these extensive epidemiological cohorts comprising hundreds of thousands of participants, variations at this locus show moderate-to-strong statistical associations with circulating levels of total cholesterol, LDL-C, and triglycerides. The catalog evidence strength for rs780632 is classified as Moderate. While rs780632 is consistently tracked in large genomic arrays, the phenotypic effect size of any individual common non-coding variant is modest. Typically, carrying one or two trait-associated alleles shifts average blood lipid levels by only a fraction of a milligram per deciliter (mg/dL). Furthermore, because regulatory loci often function in polygenic networks, the net biological outcome represents an aggregate effect across dozens or hundreds of independent genomic sites rather than a single deterministic genetic switch.
Population Frequency Across Ancestries
The rs780632 polymorphism is a common, segregating variant across global human populations. In individuals of European ancestry, the minor allele frequency typically spans approximately 40% to 50%, making heterozygous and homozygous genotypes remarkably prevalent in the general public. Similar common frequencies are documented across East Asian, South Asian, and African reference panels in population genetics resources like dbSNP and gnomAD, although precise minor allele frequencies fluctuate between distinct ancestral groups. Because both the ancestral and variant alleles have circulated in human populations for tens of thousands of years, neither form is considered abnormal or pathogenic.
Interpreting Your Results: Scope and Limitations
Genotype data for rs780632 must be interpreted with an educational, population-level mindset. Having a genotype statistically correlated with higher triglycerides or LDL-C does not mean an individual is destined to develop hyperlipidemia, atherosclerosis, or cardiovascular disease. Genetics accounts for only part of total lipid variance; modifiable environmental factors, including dietary habits, physical activity, body mass, and age, play enormous roles in shaping an individual's real-world lipid profile. Direct-to-consumer genetic information cannot substitute for a clinical lipid panel. Standard blood tests measuring total cholesterol, LDL-C, HDL-C, and triglycerides remain the standard tool for evaluating cardiovascular risk. If a consumer discovers they carry a genotype linked with elevated lipids, the result cannot be used to start, stop, or alter lipid-lowering therapies. Any medication decisions—such as statin prescription or dosing—must be evaluated and managed exclusively by a qualified healthcare professional or pharmacist.
How common is this variant?
The minor allele frequency for rs780632 is roughly 40% to 50% in European populations, and the variant is also observed at common frequencies across East Asian, South Asian, and African reference panels.
Frequently asked questions
Does having an rs780632 risk allele mean I will definitely have high cholesterol?
No. Genetic association studies identify statistical tendencies across large populations, not individual guarantees. A single common variant exerts only a minute effect on circulating cholesterol or triglycerides, and many individuals with trait-associated alleles maintain normal lipid levels through lifestyle and overall biology.
Can my rs780632 genotype tell my doctor whether I need a statin?
No. Clinical guidelines for statin therapy are based on validated cardiovascular risk calculations, measured blood lipid panels, blood pressure, age, and overall medical history, not individual non-coding SNPs like rs780632. Always discuss cardiovascular risk and medication choices directly with your physician.
Why do researchers study non-coding variants near the TRIB1 gene?
Although intronic and non-coding variants do not alter protein structures directly, they frequently influence enhancer or promoter activity that regulates how much of a protein is synthesized. Investigating these variants helps scientists pinpoint regulatory mechanisms that control hepatic lipid metabolism.
How common is rs780632 in the general population?
It is exceptionally common. In European populations, the minor allele frequency ranges between approximately 40% and 50%, and the variant is also widely documented across other global ancestries. Consequently, carrying one or two copies of this variant is a routine human genetic variation.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs780632?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TRIB1
This variant is located near the TRIB1 gene and is associated with blood lipid levels and coronary heart disease risk in Chinese Han populations.
While primarily linked to lipid metabolism, this variant is increasingly studied for its role in phenotypic variability and metabolic traits affecting overall appearance.